Literature DB >> 23853092

Histone deacetylase 7 promotes Toll-like receptor 4-dependent proinflammatory gene expression in macrophages.

Melanie R Shakespear1, Daniel M Hohenhaus, Greg M Kelly, Nabilah A Kamal, Praveer Gupta, Larisa I Labzin, Kate Schroder, Valerie Garceau, Sheila Barbero, Abishek Iyer, David A Hume, Robert C Reid, Katharine M Irvine, David P Fairlie, Matthew J Sweet.   

Abstract

Broad-spectrum inhibitors of histone deacetylases (HDACs) constrain Toll-like receptor (TLR)-inducible production of key proinflammatory mediators. Here we investigated HDAC-dependent inflammatory responses in mouse macrophages. Of the classical Hdacs, Hdac7 was expressed at elevated levels in inflammatory macrophages (thioglycollate-elicited peritoneal macrophages) as compared with bone marrow-derived macrophages and the RAW264 cell line. Overexpression of a specific, alternatively spliced isoform of Hdac7 lacking the N-terminal 22 amino acids (Hdac7-u), but not the Refseq Hdac7 (Hdac7-s), promoted LPS-inducible expression of Hdac-dependent genes (Edn1, Il-12p40, and Il-6) in RAW264 cells. A novel class IIa-selective HDAC inhibitor reduced recombinant human HDAC7 enzyme activity as well as TLR-induced production of inflammatory mediators in thioglycollate-elicited peritoneal macrophages. Both LPS and Hdac7-u up-regulated the activity of the Edn1 promoter in an HDAC-dependent fashion in RAW264 cells. A hypoxia-inducible factor (HIF) 1 binding site in this promoter was required for HDAC-dependent TLR-inducible promoter activity and for Hdac7- and HIF-1α-mediated trans-activation. Coimmunoprecipitation assays showed that both Hdac7-u and Hdac7-s interacted with HIF-1α, whereas only Hdac7-s interacted with the transcriptional repressor CtBP1. Thus, Hdac7-u positively regulates HIF-1α-dependent TLR signaling in macrophages, whereas an interaction with CtBP1 likely prevents Hdac7-s from exerting this effect. Hdac7 may represent a potential inflammatory disease target.

Entities:  

Keywords:  Histone Deacetylase; Hypoxia-inducible Factor (HIF); Inflammation; Macrophages; Toll-like Receptor (TLR)

Mesh:

Substances:

Year:  2013        PMID: 23853092      PMCID: PMC3757200          DOI: 10.1074/jbc.M113.496281

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  A dynamic role for HDAC7 in MEF2-mediated muscle differentiation.

Authors:  U Dressel; P J Bailey; S C Wang; M Downes; R M Evans; G E Muscat
Journal:  J Biol Chem       Date:  2001-03-08       Impact factor: 5.157

2.  Molecular cloning and characterization of a novel histone deacetylase HDAC10.

Authors:  Amaris R Guardiola; Tso-Pang Yao
Journal:  J Biol Chem       Date:  2001-11-28       Impact factor: 5.157

3.  Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor.

Authors:  C L Zhang; T A McKinsey; J R Lu; E N Olson
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

4.  Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo.

Authors:  W Fischle; F Dequiedt; M Fillion; M J Hendzel; W Voelter; E Verdin
Journal:  J Biol Chem       Date:  2001-07-20       Impact factor: 5.157

5.  The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines.

Authors:  Flavio Leoni; Andrea Zaliani; Giorgio Bertolini; Giulia Porro; Paolo Pagani; Pietro Pozzi; Giancarlo Donà; Gianluca Fossati; Silvano Sozzani; Tania Azam; Philip Bufler; Giamila Fantuzzi; Igor Goncharov; Soo-Hyun Kim; Benjamin J Pomerantz; Leonid L Reznikov; Britta Siegmund; Charles A Dinarello; Paolo Mascagni
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

6.  The molecular basis for the lack of immunostimulatory activity of vertebrate DNA.

Authors:  Katryn J Stacey; Greg R Young; Francis Clark; David P Sester; Tara L Roberts; Shalin Naik; Matthew J Sweet; David A Hume
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

7.  Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein.

Authors:  Jong Sung Park; Daiva Svetkauskaite; Qianbin He; Jae-Yeol Kim; Derek Strassheim; Akitoshi Ishizaka; Edward Abraham
Journal:  J Biol Chem       Date:  2003-12-04       Impact factor: 5.157

8.  Deacetylase inhibition promotes the generation and function of regulatory T cells.

Authors:  Ran Tao; Edwin F de Zoeten; Engin Ozkaynak; Chunxia Chen; Liqing Wang; Paige M Porrett; Bin Li; Laurence A Turka; Eric N Olson; Mark I Greene; Andrew D Wells; Wayne W Hancock
Journal:  Nat Med       Date:  2007-10-07       Impact factor: 53.440

9.  Histone deacetylase 7 associates with hypoxia-inducible factor 1alpha and increases transcriptional activity.

Authors:  Hiroyuki Kato; Shiori Tamamizu-Kato; Futoshi Shibasaki
Journal:  J Biol Chem       Date:  2004-07-26       Impact factor: 5.157

10.  Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha.

Authors:  Caroline C Blouin; Elisabeth L Pagé; Guylaine M Soucy; Darren E Richard
Journal:  Blood       Date:  2003-10-02       Impact factor: 22.113

View more
  31 in total

1.  Detection of proneural/mesenchymal marker expression in glioblastoma: temporospatial dynamics and association with chromatin-modifying gene expression.

Authors:  Hideki Murata; Koji Yoshimoto; Ryusuke Hatae; Yojiro Akagi; Masahiro Mizoguchi; Nobuhiro Hata; Daisuke Kuga; Akira Nakamizo; Toshiyuki Amano; Tetsuro Sayama; Koji Iihara
Journal:  J Neurooncol       Date:  2015-08-14       Impact factor: 4.130

Review 2.  An overview of naturally occurring histone deacetylase inhibitors.

Authors:  Bumki Kim; Jiyong Hong
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

3.  Regulation of Nitrogen Mustard-Induced Lung Macrophage Activation by Valproic Acid, a Histone Deacetylase Inhibitor.

Authors:  Alessandro Venosa; James G Gow; LeRoy Hall; Rama Malaviya; Andrew J Gow; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Sci       Date:  2017-05-01       Impact factor: 4.849

Review 4.  Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders.

Authors:  Katrina J Falkenberg; Ricky W Johnstone
Journal:  Nat Rev Drug Discov       Date:  2014-08-18       Impact factor: 84.694

Review 5.  Epigenetic Regulation of Monocyte and Macrophage Function.

Authors:  Marten A Hoeksema; Menno P J de Winther
Journal:  Antioxid Redox Signal       Date:  2016-04-25       Impact factor: 8.401

Review 6.  Epigenetics and innate immunity: the 'unTolld' story.

Authors:  Conor Hennessy; Declan P McKernan
Journal:  Immunol Cell Biol       Date:  2016-02-29       Impact factor: 5.126

7.  Histone Deacetylase Inhibitors Promote Mitochondrial Reactive Oxygen Species Production and Bacterial Clearance by Human Macrophages.

Authors:  Juliana K Ariffin; Kaustav das Gupta; Ronan Kapetanovic; Abishek Iyer; Robert C Reid; David P Fairlie; Matthew J Sweet
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

8.  HDAC7 modulates TNF-α-mediated suppression of Leydig cell steroidogenesis.

Authors:  Mohanraj Sadasivam; Balamurugan Ramatchandirin; Sivasangari Balakrishnan; Chidambaram Prahalathan
Journal:  Mol Cell Biochem       Date:  2015-04-28       Impact factor: 3.396

9.  HDAC is essential for epigenetic regulation of Thy-1 gene expression during LPS/TLR4-mediated proliferation of lung fibroblasts.

Authors:  Shunpeng Xing; Fang Nie; Qiaoyi Xu; Yuxiao Deng; Wen Li; Zhongwei Yang; Xianyuan Zhao; Ping Zhu; Xiangrui Wang; Yuan Gao; Zhengyu He
Journal:  Lab Invest       Date:  2015-07-27       Impact factor: 5.662

10.  Histone deacetylase 9 represses cholesterol efflux and alternatively activated macrophages in atherosclerosis development.

Authors:  Qiang Cao; Shunxing Rong; Joyce J Repa; Richard St Clair; John S Parks; Nilamadhab Mishra
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-07-17       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.